FDA warns of counterfeit drug sales

The Food and Drug Administration has posted a warning on its Web site advising consumers not to order prescriptions online from sites that offer drugs through the Mediplan Prescription Plus Pharmacy or Mediplan Global Health in Manitoba, Sask., Canada.

The FDA said there are reports that these companies are selling counterfeit versions of prescription drug to Americans, and is advising consumers who have had prescriptions filled through these Web sites not use the products.

The agency said it is investigating the reports and is 'coordinating with international law enforcement authorities on this matter.'

The FDA said preliminary laboratory results to date have found counterfeits of the following drugs: Lipitor, Diovan, Actonel, Nexium, Hyzaar, Ezetrol (known as Zetia in the United States), Crestor, Celebrex, Arimidex and Propecia. All of these medications require a prescription from a licensed health care provider to be legally dispensed.

The FDA said some of the sites operated by Mediplan or that fill orders through Mediplan include:
'www.Canada-Meds-For-Less.net; and

About the Author

David Hubler is the former print managing editor for GCN and senior editor for Washington Technology. He is freelance writer living in Annandale, Va.


  • business meeting (Monkey Business Images/Shutterstock.com)

    Civic tech volunteers help states with legacy systems

    As COVID-19 exposed vulnerabilities in state and local government IT systems, the newly formed U.S. Digital Response stepped in to help. Its successes offer insight into existing barriers and the future of the civic tech movement.

  • data analytics (Shutterstock.com)

    More visible data helps drive DOD decision-making

    CDOs in the Defense Department are opening up their data to take advantage of artificial intelligence and machine learning tools that help surface insights and improve decision-making.

Stay Connected